Effects of prophylactic drug therapies and anti-calcitonin peptide-related monoclonal antibodies on subjective sleep quality: An Italian multicenter study
Open Access
- 17 March 2024
- journal article
- research article
- Published by Elsevier in Sleep Medicine
- Vol. 117, 87-94
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Prevalence of headaches and their relationship with obstructive sleep apnea (OSA) - Systematic review and meta-analysisSleep Medicine Reviews, 2023
- Relationship between sleep problems and headaches among adolescents: Pelotas 2004 Birth cohortSleep Medicine: X, 2023
- Off‐label low dose amitriptyline for insomnia disorder: Patient‐reported outcomesPharmacoepidemiology and Drug Safety, 2022
- Poor sleep quality in patients affected by migraine: a population studyNeurological Sciences, 2020
- Influence of chronotype on migraine characteristicsNeurological Sciences, 2019
- Diverse Physiological Roles of Calcitonin Gene-Related Peptide in Migraine Pathology: Modulation of Neuronal-Glial-Immune Cells to Promote Peripheral and Central SensitizationCurrent Pain and Headache Reports, 2016
- Calcitonin Gene-Related Peptide Neurons Mediate Sleep-Specific Circadian Output in DrosophilaCurrent Biology, 2014
- Associations between sleep disturbance and primary headaches: the third Nord-Trøndelag Health StudyThe Journal of Headache and Pain, 2010
- Headache and sleep: clinical and therapeutical aspectsThe Journal of Headache and Pain, 2004
- The Pittsburgh sleep quality index: A new instrument for psychiatric practice and researchPsychiatry Research, 1989